haloperidol has been researched along with dronabinol in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (35.71) | 18.7374 |
| 1990's | 3 (7.14) | 18.2507 |
| 2000's | 13 (30.95) | 29.6817 |
| 2010's | 10 (23.81) | 24.3611 |
| 2020's | 1 (2.38) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chesher, GB; Jackson, DM; Malor, R; Zaluzny, SG | 1 |
| Buyniski, JP; Doran, KM; Gylys, JA | 1 |
| Gough, AL; Gough, NE | 1 |
| Atweh, S; Kuhar, MJ; Simon, JR | 1 |
| Friedman, E; Gershon, S; Hine, B; Torrelio, M | 1 |
| Gold, LH; Martin, BR; Prescott, WR | 1 |
| Gao, XK; Song, B | 1 |
| Fujiwara, M; Kiyota, Y; Ohta, H; Sakurai, Y; Shibata, S; Shimazoe, T; Ueki, S | 1 |
| Fujiwara, M; Kataoka, Y; Ohta, H; Sakurai, Y; Shimazoe, T; Ueki, S | 1 |
| Murakami, M; Ota, K | 1 |
| Fujiwara, M; Kataoka, Y; Ohta, H; Oishi, R; Ueki, S | 1 |
| Lemberger, L | 1 |
| Järbe, TU | 1 |
| Davies, JA; Graham, JD | 1 |
| Heppner, GH; Levy, JA | 1 |
| Koe, BK | 1 |
| Hasegawa, T; Kameyama, T; Katsumata, Y; Kinoshita, H; Nabeshima, T; Yamamoto, I | 1 |
| Hasegawa, T; Kameyama, T; Kinoshita, H; Nabeshima, T; Yamamoto, I | 1 |
| Casti, P; Casu, G; Marchese, G; Pani, L; Ruiu, S; Saba, P; Sanna, A | 1 |
| Egashira, N; Fujiwara, M; Iwasaki, K; Mishima, K; Mizuki, A; Nagai, H; Nishimura, R; Ogata, A; Sano, K; Shoyama, Y | 1 |
| Egashira, N; Fujiwara, M; Ishigami, N; Iwasaki, K; Mishima, K; Oishi, R | 1 |
| Bhakta, S; Blaise, R; Braley, G; Cooper, T; D'Souza, DC; Oliver, S; Perry, E; Pittman, B; Ranganathan, M; Vendetti, M; Zimolo, Z | 1 |
| Burston, JJ; Howard, DR; Kendler, SH; Selley, DE; Sim-Selley, LJ; Wiley, JL | 1 |
| Casti, P; Casu, G; Marchese, G; Pani, L; Ruiu, S; Sanna, A; Spada, GP | 1 |
| Evans, RL; Wiley, JL | 1 |
| de Kam, ML; Franson, KL; Hijman, R; Kahn, RS; Liem-Moolenaar, M; te Beek, ET; Touw, D; van Gerven, JM | 1 |
| Angelucci, F; Bernardi, G; Caltagirone, C; Cantarella, C; Castelli, M; Cavasinni, F; Centonze, D; De Chiara, V; Maccarrone, M; Mataluni, G; Musella, A; Napolitano, F; Rossi, S; Sacchetti, L; Usiello, A | 1 |
| Body, S; Bradshaw, CM; Cassaday, HJ; Goudie, AJ; Olarte-Sánchez, CM; Szabadi, E; Valencia Torres, L | 1 |
| Carroll, FI; McMahon, LR; Schulze, DR | 1 |
| Ginovart, N; Tournier, BB | 1 |
| Echeverry-Alzate, V; Giné, E; Lopez-Moreno, JA; Perez-Castillo, A; Rodriguez de Fonseca, F; Santos, A | 1 |
| Egashira, N; Iwasaki, K; Kinjo, J; Koushi, E; Mishima, K; Morimoto, S; Myose, T; Tanaka, H; Tanoue, A; Tsuchihashi, R | 1 |
| D'Souza, DC; De Aquino, JP; Gupta, S; Ranganathan, M | 1 |
| Earl, V; Howell, M; Malik, M; Rosenthal, J | 1 |
2 review(s) available for haloperidol and dronabinol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Recent advances in the management of chemotherapy-induced emesis].
Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Domperidone; Dronabinol; Drug Therapy, Combination; Haloperidol; Humans; Metoclopramide; Nausea; Neoplasms; Prochlorperazine; Vomiting | 1986 |
1 trial(s) available for haloperidol and dronabinol
| Article | Year |
|---|---|
Central nervous system effects of haloperidol on THC in healthy male volunteers.
Topics: Adult; Affect; Antipsychotic Agents; Attention; Central Nervous System; Cognition; Cross-Over Studies; Double-Blind Method; Dronabinol; Electroencephalography; Hallucinogens; Haloperidol; Humans; Male; Psychiatric Status Rating Scales; Psychomotor Performance; Pursuit, Smooth; Young Adult | 2010 |
39 other study(ies) available for haloperidol and dronabinol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The attenuation of delta 9-tetrahydrocannabinol and morphine of the quasi-morphine withdrawal syndrome in rats.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Behavior, Animal; Chlordiazepoxide; Dronabinol; Haloperidol; Humans; Male; Morphine; Morphine Dependence; Naloxone; Rats; Substance Withdrawal Syndrome | 1979 |
Antagonism of cisplatin induced emesis in the dog.
Topics: Animals; Antiemetics; Chlorpromazine; Cisplatin; Dogs; Dronabinol; Female; Haloperidol; Indoles; Male; Metoclopramide; Piperidines; Vomiting | 1979 |
Computer analysis of interacting dopaminergic and cholinergic control mechanisms in the extrapyramidal system.
Topics: Acetylcholine; Animals; Computers; Dopamine; Dronabinol; Extrapyramidal Tracts; Feedback; Haloperidol; Models, Neurological; Rats | 1978 |
Utilization of sodium-dependent high affinity choline uptake in vitro as a measure of the activity of cholinergic neurons in vivo.
Topics: Animals; Atropine; Biological Transport, Active; Brain; Cell-Free System; Cerebral Cortex; Choline; Corpus Striatum; Dronabinol; Haloperidol; Hippocampus; Male; Mice; Morphine; Neurons; Pentobarbital; Pentylenetetrazole; Rats; Scopolamine; Sodium; Synaptosomes | 1975 |
Tetrahydrocannabinol-attenuated abstinence and induced rotation in morphine-dependent rats: possible involvement of dopamine.
Topics: Animals; Behavior; Cannabis; Dopamine; Dronabinol; Haloperidol; Humans; Male; Morphine Dependence; Naloxone; Promethazine; Rats; Stereotyped Behavior; Substance Withdrawal Syndrome; Time Factors | 1975 |
Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta 9-THC in the rat.
Topics: Animals; Catalepsy; Discrimination, Psychological; Dose-Response Relationship, Drug; Dronabinol; Haloperidol; Male; Morphine; Nervous System; Rats; Rats, Inbred Strains; Time Factors | 1992 |
[Comparison between the catalepsies induced by delta 9-tetrahydro-cannabinol and haloperidol in rats].
Topics: Animals; Catalepsy; Dronabinol; Female; Haloperidol; Male; Rats | 1987 |
[Behavioral pharmacology of amantadine with special references to the effect on abnormal behavior in mice and rats].
Topics: Aggression; Amantadine; Animals; Behavior, Animal; Catalepsy; Central Nervous System; Dronabinol; Haloperidol; Humans; Male; Methamphetamine; Mice; Motor Activity; Predatory Behavior; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1985 |
delta 9-Tetrahydrocannabinol elicited ipsilateral circling behavior in rats with unilateral nigral lesion.
Topics: Animals; Apomorphine; Behavior, Animal; Dopamine; Dronabinol; Haloperidol; Hydroxydopamines; Male; Methamphetamine; Neurons; Oxidopamine; Rats; Rats, Inbred Strains; Substantia Nigra | 1985 |
Noradrenergic involvement in catalepsy induced by delta 9-tetrahydrocannabinol.
Topics: Animals; Brain; Catalepsy; Desipramine; Dopamine; Dronabinol; Haloperidol; Hydroxydopamines; Locus Coeruleus; Male; Norepinephrine; Oxidopamine; Rats; Serotonin | 1987 |
Role of drug metabolism in drug research and development: importance of drug metabolism in clinical pharmacological evaluation of new drugs.
Topics: Administration, Oral; Amphetamine; Animals; Bicarbonates; Biopharmaceutics; Butanes; Chlorpromazine; Dogs; Dronabinol; Feces; Guinea Pigs; Half-Life; Haloperidol; Humans; Injections, Intravenous; Kinetics; Methoxamine; Pharmaceutical Preparations; Rabbits; Rats; Research; Species Specificity; Tritium | 1972 |
Discriminative stimulus properties of cocaine. Effects of apomorphine, haloperidol, procaine and other drugs.
Topics: Animals; Apomorphine; Cocaine; Columbidae; Cues; Discrimination Learning; Dronabinol; Generalization, Stimulus; Haloperidol; Lysergic Acid Diethylamide; Male; Pentobarbital; Procaine | 1984 |
The mechanism of action of delta 9-tetrahydrocannabinol on body temperature in mice.
Topics: Animals; Biogenic Amines; Body Temperature; Clomipramine; Dronabinol; Fenclonine; Haloperidol; Male; Methysergide; Mice; Phenoxybenzamine | 1980 |
Alterations of immune reactivity by haloperidol and delta-9-tetrahydrocannabinol.
Topics: Animals; Antibody Formation; Behavior, Animal; Dronabinol; Haloperidol; Hemagglutination Tests; Hemolytic Plaque Technique; Hypersensitivity, Delayed; Immunity; Immunity, Cellular; Male; Mice | 1981 |
Levonantradol, a potent cannabinoid-related analgesic, antagonizes haloperidol-induced activation of striatal dopamine synthesis.
Topics: Analgesics; Animals; Corpus Striatum; Dopamine; Dronabinol; gamma-Aminobutyric Acid; Haloperidol; Male; Phenanthridines; Rats; Receptors, Dopamine; Stereoisomerism | 1981 |
Effect of dizocilpine (MK-801) on the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
Topics: Acetylcholine; Animals; Catalepsy; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Dronabinol; Haloperidol; Male; Mice; Oxotremorine; Parkinson Disease; Receptors, N-Methyl-D-Aspartate | 1994 |
Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
Topics: 2-Amino-5-phosphonovalerate; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amantadine; Amino Acids; Animals; Anticonvulsants; Catalepsy; Dizocilpine Maleate; Dopamine Agonists; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Ergolines; Haloperidol; Male; Mice; Mice, Inbred Strains; Motor Activity; Piperazines; Quinpirole; Receptors, N-Methyl-D-Aspartate; Scopolamine | 1994 |
Haloperidol, but not clozapine, produces dramatic catalepsy in delta9-THC-treated rats: possible clinical implications.
Topics: Animals; Catalepsy; Clozapine; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Haloperidol; Male; Protein Binding; Rats; Rats, Sprague-Dawley | 2003 |
Antipsychotics improve Delta9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice.
Topics: Acoustic Stimulation; Animals; Antipsychotic Agents; Dopamine; Dronabinol; Haloperidol; Inhibition, Psychological; Male; Mice; Nucleus Accumbens; Piperidines; Prefrontal Cortex; Pyrazoles; Reflex, Startle; Rimonabant; Risperidone; Rotarod Performance Test | 2006 |
Delta9-Tetrahydrocannabinol-induced cognitive deficits are reversed by olanzapine but not haloperidol in rats.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Cognition Disorders; Dronabinol; Extracellular Space; Hallucinogens; Haloperidol; Hippocampus; Humans; Male; Marijuana Abuse; Maze Learning; Memory Disorders; Microdialysis; Olanzapine; Rats; Rats, Wistar | 2008 |
Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.
Topics: Adolescent; Adult; Antipsychotic Agents; Behavior; Cognition; Dronabinol; Euphoria; Female; Hallucinogens; Haloperidol; Humans; Male; Marijuana Smoking; Memory, Short-Term; Middle Aged; Motor Activity; Neuropsychological Tests; Neurosecretory Systems; Psychomotor Performance; Substance Abuse Detection; Visual Perception | 2008 |
Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in rats.
Topics: Aging; Animals; Antipsychotic Agents; Cells, Cultured; CHO Cells; Clozapine; Cricetinae; Cricetulus; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Dronabinol; Female; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Male; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Rimonabant; Sex Characteristics; Signal Transduction | 2008 |
Delta-9-tetrahydrocannabinol differently affects striatal c-Fos expression following haloperidol or clozapine administration.
Topics: Animals; Antipsychotic Agents; Blotting, Western; Clozapine; Dronabinol; Gene Expression; Genes, fos; Haloperidol; Immunohistochemistry; Male; Neostriatum; Neurons; Piperidines; Psychotropic Drugs; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant | 2008 |
To breed or not to breed? Empirical evaluation of drug effects in adolescent rats.
Topics: Aging; Animals; Antipsychotic Agents; Breeding; Catalepsy; Clozapine; Dose-Response Relationship, Drug; Dronabinol; Drug Tolerance; Environment; Female; Haloperidol; Male; Motor Activity; Neuropharmacology; Pain Threshold; Psychotropic Drugs; Rats; Rats, Long-Evans; Sex Characteristics; Stress, Psychological | 2009 |
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum.
Topics: Animals; Behavior, Animal; beta-Cyclodextrins; Brain-Derived Neurotrophic Factor; Cholesterol; Cocaine; Corpus Striatum; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dronabinol; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; GABA Agents; Haloperidol; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons; Patch-Clamp Techniques; Phenols; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Reward | 2010 |
A clozapine-like effect of cyproheptadine on progressive ratio schedule performance.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Chlordiazepoxide; Clozapine; Conditioning, Operant; Cyproheptadine; Dronabinol; Eating; Female; Haloperidol; Motivation; Performance-Enhancing Substances; Psychomotor Performance; Rats; Rats, Wistar; Reinforcement Schedule; Reinforcement, Psychology | 2012 |
Interactions between dopamine transporter and cannabinoid receptor ligands in rhesus monkeys.
Topics: Amphetamine; Animals; Cocaine; Discrimination Learning; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Dronabinol; Female; Haloperidol; Imipramine; Macaca mulatta; Male; Piperidines; Pyrazoles; Receptors, Cannabinoid; Rimonabant; Tropanes | 2012 |
Repeated but not acute treatment with ∆⁹-tetrahydrocannabinol disrupts prepulse inhibition of the acoustic startle: reversal by the dopamine D₂/₃ receptor antagonist haloperidol.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Disease Models, Animal; Dopamine Antagonists; Dronabinol; Gait Disorders, Neurologic; Hallucinogens; Haloperidol; Male; Prepulse Inhibition; Psychoacoustics; Rats; Rats, Sprague-Dawley; Time Factors | 2014 |
The CB1 receptor is required for the establishment of the hyperlocomotor phenotype in developmentally-induced hypothyroidism in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Brain; Cannabinoid Receptor Agonists; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dronabinol; Haloperidol; Hypothyroidism; Imidazoles; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Perchlorates; Phenotype; Potassium Compounds; Receptor, Cannabinoid, CB1; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2017 |
Role of vasopressin V1a receptor in ∆
Topics: Animals; Cannabinoid Receptor Agonists; Cannabinoids; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Haloperidol; Immobilization; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Random Allocation; Receptors, Vasopressin | 2017 |
Effects of haloperidol on the delta-9-tetrahydrocannabinol response in humans: a responder analysis.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Dopamine Antagonists; Double-Blind Method; Dronabinol; Female; Haloperidol; Humans; Male; Perception; Psychotic Disorders; Psychotropic Drugs; Young Adult | 2019 |
Cannabinoid Hyperemesis Syndrome Secondary to Delta-8 THC Use.
Topics: Administration, Cutaneous; Adult; Antiemetics; Cannabinoid Receptor Agonists; Capsaicin; Dopamine Antagonists; Dronabinol; Female; Fluid Therapy; Haloperidol; Humans; Nausea; Sensory System Agents; Vomiting | 2021 |